INIS
infants
100%
children
99%
newborns
75%
reviews
66%
proteins
58%
risks
58%
data
53%
patients
50%
injuries
47%
inflammation
44%
comparative evaluations
38%
lungs
37%
ventilation
36%
diseases
36%
covid-19
33%
hypoxia
32%
surfactants
29%
humans
29%
surveys
29%
obesity
28%
growth
28%
sex
27%
interventions
26%
sheep
26%
levels
26%
defects
25%
neonates
25%
viruses
25%
mortality
24%
birth
24%
weight
24%
endoplasmic reticulum
23%
volume
21%
losses
20%
ischemia
20%
growth factors
20%
barriers
20%
blood pressure
19%
range
19%
pregnancy
19%
therapy
18%
information
18%
netherlands
18%
gain
18%
schools
17%
quality of life
17%
stem cells
16%
heart disease
16%
congenital diseases
16%
women
16%
pathology
16%
patents
16%
concentration
16%
values
16%
pediatrics
16%
assessments
15%
europe
14%
lambs
14%
failures
14%
messenger-rna
14%
layers
14%
control
14%
implementation
13%
adults
12%
phospholipids
12%
animals
12%
education
12%
interleukins
11%
blood
11%
brain
11%
galactose
11%
populations
11%
epithelium
10%
mitochondria
10%
applications
10%
height
10%
nutrition
10%
testing
10%
protection
9%
air
9%
policy
9%
fluorescence
9%
hypertension
9%
glucose
9%
surgery
9%
lavage
9%
cost
9%
management
9%
dissociation
9%
administration
9%
closures
9%
adolescents
9%
endothelium
9%
charts
8%
screens
8%
sweden
8%
france
8%
in vitro
8%
hospitals
8%
aldehydes
8%
Keyphrases
Chorioamnionitis
55%
Standard of Care
34%
Preterm Infants
34%
Necrotizing Enterocolitis
33%
COVID-19 Pandemic
33%
European Standards
33%
Newborn Health
33%
Bronchopulmonary Dysplasia
31%
Ovine
27%
Systematic Meta-analysis
25%
Surfactant Protein A (SP-A)
25%
Meta-regression
25%
Respiratory Syncytial Virus Infection
25%
Respiratory Syncytial Virus
25%
Neonatal Care
21%
Netherlands
19%
Young children
19%
Europe
18%
Hypoxia
18%
Goblet Cells
18%
Protective Effect
17%
Oxygenation
17%
Gestational Age
17%
Sheep
16%
Noninvasive Ventilation
16%
IVF-ICSI
16%
Accelerated Growth
16%
Intestinal Goblet Cells
16%
Patent Ductus Arteriosus
16%
Parental Experience
16%
Acute Respiratory Distress Syndrome
16%
Average Volume Assured Pressure Support
16%
Lifestyle Intervention
16%
Impaired Endothelial Function
16%
Preterm Neonates
16%
ICSI children
16%
Re-epithelialization
16%
Transforming Growth factor-β1 (TGF-β1)
16%
Bayesian Analysis
16%
Randomized Controlled Trial
16%
Ureaplasma Infection
16%
Increased Blood Pressure
16%
Galactosemia
16%
Meta-analysis Regression
16%
Individualized Developmental Care
16%
Sex-disaggregated
16%
Health-related Quality of Life
16%
European Studies
16%
SpO2
16%
Prospective Meta-analysis
16%
Endoplasmic Reticulum Stress (ER stress)
16%
Dutch
14%
Preterm Birth
14%
Healthcare Professionals
14%
Hypoxia-ischemia
14%
France
14%
Global Hypoxia
13%
Intensive Care
13%
Gut Inflammation
13%
Ureaplasma Parvum
13%
Late-onset Sepsis
12%
Large-for-gestational-age
12%
Pathophysiology
12%
Sweden
11%
Sex Differences
11%
Mechanical Ventilation
11%
Intestinal Inflammation
11%
Neonatology
11%
Pan-European
11%
Retinopathy of Prematurity
11%
Mucus Barrier
10%
Congenital Heart Disease
10%
Fetal Lambs
10%
During Pregnancy
10%
B Cells
10%
Weight Gain
10%
Immunization
10%
Messenger RNA (mRNA)
10%
Lung
10%
Small Intestine
10%
Funisitis
10%
Quality of Life
9%
Confidence Interval
9%
Neonate
9%
Family Study
9%
Overweight or Obesity
9%
Prematurity
9%
School Closure
9%
Gut Injury
9%
Fetal Sheep
9%
Goblet Cell Loss
9%
Online Questionnaire
9%
Italy
9%
Ovine Model
9%
Pediatricians
9%
Meta-analysis
8%
Organoid Models
8%
Phospholipid Composition
8%
Wheezing
8%
Cyclophosphamide
8%
Medicine and Dentistry
Meta-Analysis
59%
Neonatal Infant
51%
Chorioamnionitis
46%
Necrotizing Enterocolitis
35%
Artificial Respiration
33%
COVID-19
33%
Lung Dysplasia
33%
Systematic Review
25%
Hypoxia
23%
Newborn Care
22%
Cohort Analysis
20%
Premature Labor
20%
Prematurity
20%
Gut
18%
Lung
18%
Goblet Cell
18%
Randomized Controlled Trial
16%
Meta-Regression
16%
Lifestyle Intervention
16%
Patent Ductus Arteriosus
16%
Intracytoplasmic Sperm Injection
16%
Epithelization
16%
Elevated Blood Pressure
16%
Ureaplasma Infection
16%
Endothelial Function
16%
Mucus
15%
Respiratory Failure
14%
Physical Activity
14%
Ischemia
14%
Retinopathy of Prematurity
13%
Intensive Care
13%
Sepsis
12%
Health Outcomes
12%
Neonatology
12%
Sex Difference
12%
Persistent Truncus Arteriosus
12%
Endoplasmic Reticulum Stress
11%
Quality of Life
10%
Funisitis
9%
Cost-Effectiveness Analysis
9%
Cell Loss
9%
Drug Therapy
9%
Probiotics
9%
Pediatrician
9%
Surfactant
8%
Healthy Lifestyle
8%
Hypoglycemia
8%
Acute Respiratory Distress Syndrome
8%
Congenital Heart Defect
8%
Asphyxia
8%
Interleukin 2
8%
Cyanotic Heart Defect
8%
Asthma
8%
Wheeze
8%
Chronic Obstructive Pulmonary Disease
8%
Breathing
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Morbid Obesity
8%
Pediatric Nutrition
8%
Neonatal Hypoglycemia
8%
Surfactant Protein A
8%
Vasculotropin
8%
Hepatology
8%
Gamma-Aminobutyric Acid
8%
Disease Exacerbation
8%
Respiratory Syncytial Virus Infection
8%
Allergic Rhinitis
8%
Cardiometabolic Risk
8%
Pulmonary Hypertension
8%
Bilevel Positive Airway Pressure
8%
Phospholipid
8%
Neonate
8%
Blood Pressure
8%
Cerebellum
8%
Mesenchymal Stem Cell
8%
Hypopnea
8%
Fetus Growth
8%
Apnea
8%
Progenitor Cell
8%
Induced Hypothermia
8%
Pediatric Gastroenterology
8%
Neonatal Sepsis
8%
Metabolic Dysfunction-Associated Steatotic Liver Disease
8%
Necrotizing Pneumonia
8%
Self-Diagnosis
8%
Offspring
8%
Endobronchial Valve
8%
Gestational Age
8%
Ureaplasma parvum
8%
Newborn Disease
6%
Serositis
6%
Hyperbarism
6%
T Cell
5%
Diseases
5%
Cross Sectional Study
5%
Human Respiratory Syncytial Virus
5%
Body Mass Index
5%
Enteritis
5%
Odds Ratio
5%
Perinatal Care
5%